WORLDWIDE CONTACT US ABOUT US PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Home HARNESSING THE POWER OF THE IMMUNE SYSTEM Merck scientists talk about being on the verge of a new era in cancer therapy Merck’s immuno-oncology researchers are focused on finding ways to help the immune system recognize cancer cells as well as strengthen the body’s response to destroy them. WATCH THE VIDEO Here, Eric Rubin, vice president, Clinical Research, Oncology Early Development; Reshma Rangwala, senior principal scientist, Clinical Research; and Scot Ebbinghaus, executive director, Clinical Research, Oncology, talk about their work in this space and how they are committed to finding ways to transform how we treat cancer. “When we get new data, it’s truly an exciting event not only for me personally but for the entire team of physicians and scientists who work with me every single day.” — Reshma Rangwala senior principal scientist, Clinical Research LEARN MORE ABOUT IMMUNO-ONOCOLOGY VIEW INFOGRAPHIC Copyright © 2009-2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map

WORLDWIDE CONTACT US ABOUT US PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Home PERSPECTIVES ON … MERCK FELLOWSHIP FOR GLOBAL HEALTH About Us Corporate Responsibility Reimbursement Support and Patient Assistance Programs Leadership Board of Directors Executive Committee Our Work How We Operate Code of Conduct Compliance Privacy Transparency and Privacy Internet Privacy Policy Cookie Privacy Commitment Cross Border Policy Employment Privacy & Data Protection Diversity Employee Diversity Supplier Diversity Views and Positions Access and Affordability Access to Investigational Medicines Innovation Quality and Safety Sales and Marketing Responsible Public Policy and Advocacy Our History Our People Featured Stories Meet some of this year’s Fellows, Merck employees paired with nonprofits around the world to provide meaningful and systematic improvements in health care for people in the greatest need. The Merck Fellowship for Global Health The Merck Fellowship for Global Health is a three-month, field-based corporate pro-bono program that transforms highly-qualified Merck and MSD employees into Fellows who are ready, willing and able to help nonprofit organizations fulfill their missions. The Fellowship program is one way that our company demonstrates its commitment to saving and improving lives, bringing together the passion, purpose and commitment of dedicated, talented people to achieve measurable outcomes. Here, four Fellows share their experiences. Audrey Chen Susan Galea Tania Kunda Scott Wright SHARE: Learn more about our Fellowship for Global Health Copyright © 2009-2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map